Sanofi (SNY) Cash & Equivalents (2009 - 2026)
Sanofi's Cash & Equivalents was $7.38 billion in the quarter ended Jun 30, 2026, down 57.5% from $17.39 billion a year earlier but up 6.5% from the prior quarter.
Powered by 
Analysis
Sanofi (SNY) Cash & Equivalents (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Cash & Equivalents at Sanofi came in at $8.65 billion, up 7.4% from the prior year.
- Cash & Equivalents shows a five-year compound annual growth rate of -11.4% (years ended Dec 2020 to Dec 2025).
- In earlier years, Cash & Equivalents was $8.05 billion in the year ended Dec 31, 2024 (-14.5%), $9.42 billion in the year ended Dec 31, 2023 (-29.8%), $13.42 billion in the year ended Dec 31, 2022 (+12.3%) and $11.95 billion in the year ended Dec 31, 2021 (-24.8%).
- Quarterly Cash & Equivalents has moved between $6.93 billion (the quarter ended Mar 31, 2026) and $17.39 billion (the quarter ended Jun 30, 2025) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in two of the last six quarters, with growth averaging 8.0%.
- The best year-over-year quarter for Cash & Equivalents over five years was the quarter ended Jun 30, 2025 (growth of 137.6%); the worst was the quarter ended Jun 30, 2026 (a decline of 57.5%).
- Per Business Quant data, SNY's Cash & Equivalents in the three quarters before the quarter ended Jun 30, 2026 was $6.93 billion (quarter ended Mar 31, 2026), $8.91 billion (quarter ended Dec 31, 2025) and $10.41 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Sanofi | 50.63 Bn | 17.15 Bn | 10.79 Bn | 7.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.25 Bn |
| Mar 31, 2026 | 6.79 Bn |
| Dec 31, 2025 | 8.99 Bn |
| Sep 30, 2025 | 10.45 Bn |
| Jun 30, 2025 | 18.01 Bn |
| Mar 31, 2025 | 8.65 Bn |
| Dec 31, 2024 | 7.74 Bn |
| Jun 30, 2024 | 7.28 Bn |
| Dec 31, 2023 | 9.64 Bn |
| Jun 30, 2023 | 8.69 Bn |
| Dec 31, 2022 | 13.58 Bn |
| Jun 30, 2022 | 7.21 Bn |
| Dec 31, 2021 | 11.44 Bn |
| Jun 30, 2021 | 11.57 Bn |
| Dec 31, 2020 | 17.12 Bn |
| Jun 30, 2020 | 17.96 Bn |
| Dec 31, 2019 | 10.56 Bn |
| Jun 30, 2019 | 7.67 Bn |
| Dec 31, 2018 | 7.92 Bn |
| Sep 30, 2018 | 141.98 Mn |
API Access
Sanofi Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();